Clinical trial
Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis
NCT00136110 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00136110 |
|---|---|
| Title | Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Sequential Clinical Trial of Sodium Valproate in ALS |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Princess Beatrix Muscle Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | Sodium Valproate |
| Enrollment | 165 |
| Start date | Apr 1, 2005 |
| Completion | Feb 1, 2007 |
| First posted | Aug 26, 2005 |
| Last update posted | May 1, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: